Products are for professional/laboratory use only.
Invivoscribe LymphoTrack® products can be used for next-generation sequencing (NGS) determination and minimal residual disease (MRD) tracking of B- and T-cell gene rearrangements in subjects suspected of lymphoproliferations.
Products are for professional/laboratory use only.
Just launched! Invivoscribe’s FLT3 ITD MRD Assay for Acute Myeloid Leukemia (AML)
Products are for professional/laboratory use only
Explore Recent Scientific Contributions Using Invivoscribe’s Products
Key opinion leaders across the world have recently published papers that discuss the advantages of using highly sensitive next-generation sequencing (NGS) for Minimal Residual Disease (MRD) testing.
Products are for professional/laboratory use only. LymphoTrack Dx IVD Assay kits are designed for the identification of gene arrangements in haematologic samples utilising NGS technologies.
Products are for professional/laboratory use only.
The immunoglobulin heavy-chain variable region gene (IgHV) mutational status is considered the gold standard for prognosis in chronic lymphocytic leukemia (CLL)1.
Products are for professional/laboratory use only.
The Invivoscribe symposiums presented during the 25th European Hematology Association Virtual Congress are now available to watch on demand.
Products are for professional/laboratory use only.
This webinar will explore how insights gained through NGS translate to the development of improved treatment of lymphoid malignancies.
Products are for professional/laboratory use only.
Abacus dx is pleased to announce the launch of the new LymphoTrack B-cell Low Positive Controls and LymphoQuant B-cell Internal Controls as part of Invivoscribe’s MRD B-Cell Bundled Solution.
Products are for professional/laboratory use only. Abacus dx is pleased to inform you that the Invivoscribe LymphoTrack Dx IVD Assays are now available.
